Attachment of the outer membrane lipoprotein (OprI) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens

Vaccine

Volumn 26, Issue 4, 2008, Pages 546-551

  Loots, Karolien ^a   Revets, Hilde ^b   Goddeeris, Bruno Maria ^a  

^a Faculty of Bioscience Engineering   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Adhesion; Mucosal surfaces; OprI; Poultry

Indexed keywords

LIPOPROTEIN; OUTER MEMBRANE PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ADHESION; CHICKEN; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNE RESPONSE; INTESTINE MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT MUCOSA; VACCINATION;

ANIMALS; BACTERIAL PROTEINS; CHICKENS; IMMUNOHISTOCHEMISTRY; INTESTINES; LIPOPROTEINS; MICROSCOPY, FLUORESCENCE; MUCOUS MEMBRANE; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; TRACHEA;

EID: 37849048908     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.030     Document Type: Article

References (24)

1. Iijima H., Takahashi I., and Kiyono H. Mucosal immune network in the gut for the control of infectious diseases. Rev Med Virol 11 (2001) 117-133
2. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 7 4 (1987) 265-276
3. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12 5 (1994) 387-400
4. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat Med 11 (2005) S45-S53
5. Janeway C.A., Travers P., Walport M., and Shlomchik M.J. The adaptive immune response. In: Lawrence E. (Ed). Immunobiology, the immune system in health and disease. 6th ed. (2005), Garland Science Publishing, New York 319-365
6. Ryan E.J., Daly L.M., and Mills K.H.G. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol 19 8 (2001) 293-304
7. Cox E., Verdonck F., Vanrompay D., and Goddeeris B.M. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res 37 (2006) 511-539
8. Singh M., and O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 17 (1999) 1075-1081
9. Medzhitov R., and Janeway Jr. C. Innate immune recognition: mechanisms and pathways. Immunol Rev 173 (2000) 89-97
10. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 15 (2003) 5-11
11. Ogra P.L., Faden H., and Welliver R.C. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14 2 (2001) 430-445
12. Revets H., Pynaert G., Grooten J., and De Baetselier P. Lipoprotein I, a TRL2/4 ligand modulates Th2 driven allergic reactions. J Immunol 174 2 (2005) 1097-1103
13. Cote-Sierra J., Bredan A., Toldos C.M., Stijlemans B., Brys L., Cornelis P., et al. Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. Infect Immun 70 1 (2002) 240-248
14. Leitão A., Malur A., Cornelis P., and Martins C.V. Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognized by porcine cytotoxic T lymphocytes using a lipoprotein based expression system. J Virol Methods 75 (1998) 113-119
15. Baumann U., Masouri E., and Von Specht B. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections. Vaccine 22 (2004) 840-847
16. Cote-Sierra J., Jongert E., Bredan A., Gautam D.C., Parkhouse M., Cornelis P., et al. A new membrane-bound OprI lipoprotein expression vector: high production of heterologous fusion proteins in Gram(-) bacteria and the implication for oral vaccination. Gene 221 (1998) 25-34
17. De Vos D., Lim Jr. A., De Vos P., Sarniguet A., Kersters K., and Cornelis P. Detection of the outer membrane lipoprotein I and its gene in fluorescent and non-fluorescent pseudomonads: implications for taxonomy and diagnosis. J Gen Microbiol 139 (1993) 2215-2223
18. Cornelis P., Cote-Sierra J., Lim Jr. A., Malur A., Tungpradabkul S., Tazka H., et al. Development of new cloning vectors for the production of immunogenic outer membrane fusion proteins in Escherichia coli. Biotechnology 14 (1996) 203-208
19. Erdile L.F., Brandt M.A., Warakomski D.J., Westrack G.J., Sadziene A., Barbour A.G., et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OpsA. Infect Immun 61 (1993) 81-90
20. Weis J.J., Ma Y., and Erdile L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 62 (1994) 4632-4636
21. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285 (1999) 736-739
22. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Blejharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285 (1999) 732-736
23. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 8 (2001) 675-680
24. Akira S., Yamamoto M., and Takeda K. Role of adapters in Toll-like receptor signalling. Biochem Soc Trans 31 3 (2003) 637-642